Amicogen, Inc. (KOSDAQ:092040)
South Korea · Delayed Price · Currency is KRW 3,005.00
+60.00 (2.04%)
Nov 20, 2025, 3:30 PM KST
Amicogen Market Cap
Amicogen has a market cap or net worth of 163.53 billion as of November 20, 2025. Its market cap has decreased by -33.78% in one year.
Market Cap
163.53B
Enterprise Value
265.82B
Revenue
117.72B
Ranking
n/a
PE Ratio
n/a
Stock Price
3,005.00
Market Cap Chart
Since September 12, 2013, Amicogen's market cap has decreased from 237.19B to 163.53B, a decrease of -31.05%. That is a compound annual growth rate of -3.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2025 | 163.53B | -22.71% |
| Dec 30, 2024 | 211.59B | -48.65% |
| Dec 28, 2023 | 412.06B | 8.63% |
| Dec 29, 2022 | 379.32B | -38.89% |
| Dec 30, 2021 | 620.70B | -14.98% |
| Dec 30, 2020 | 730.08B | 50.94% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 86.90T |
| Celltrion | 40.78T |
| ALTEOGEN | 29.09T |
| SK Biopharmaceuticals | 9.84T |
| ABL Bio | 9.37T |
| Yuhan | 8.68T |
| Peptron | 7.80T |
| LigaChem Biosciences | 6.50T |